BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21268804)

  • 1. [Efficacy of prostaglandin E1 and systemic antibacterial therapy application in patients with diabetes mellitus and purulent-necrotic lesions of the foot].
    Podpriatov SIe; Hrabovyĭ OM; Salata VV; Zaĭtsev SV; Simonova ZIe; Korbut SM; Shyshova SIa; Rohacheva VP
    Klin Khir; 2010; (11-12):76-8. PubMed ID: 21268804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial therapy of purulent necrotic foot lesions in patients with diabetes mellitus].
    Podpriatov SIe; Larionov HM; Simonova ZIe; Tovkun VK
    Klin Khir; 2001 Aug; (8):42-7. PubMed ID: 11794111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The structure of microflora in ulcerative-necrotic lesions in patients with diabetic foot syndrome].
    Beliaeva OA; Kryzhevskiĭ VV; Rybianets IuV; Korzhik NP; Ulanovich LI; Shevchenko AV; Bezuglaia EV
    Klin Khir; 2010 Oct; (10):20-3. PubMed ID: 21290878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of vascular therapy in complex of treatment of purulent necrotic foot ulcers in patients with diabetes mellitus].
    Podpriatov SIe; Lisovets' VV; Huch AO; Tovkun VK; Slobodeniuk IM; Hupalo IuM
    Klin Khir; 2001 Feb; (2):27-9. PubMed ID: 11482020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment of purulent necrotic complications in patients with diabetic foot syndrome].
    Datsenko BM; Belov SG; Girka EI
    Klin Khir; 2001 Aug; (8):10-2. PubMed ID: 11794095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peculiarities of the occurrence of soft tissue disorders and prospects of their closure in patients with diabetes mellitus].
    Driuk MF; Podpriatov SIe; Lisovets' VV; Rohachova VP
    Klin Khir; 2001 Aug; (8):14-6. PubMed ID: 11794097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Causes of unsatisfactory outcome in patients with diabetes mellitus complicated by necrotic inflammation of the foot].
    Fedorenko VP
    Klin Khir; 1999; (3):16-9. PubMed ID: 10370287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of the glicemia level in elderly and senile patients with diabetes mellitus, operated for purulent-necrotic foot lesion].
    Ivashchenko VV; Kolkin Iag; Koval'chuk VS; Ivashchenko AV
    Klin Khir; 2005 Aug; (8):51-4. PubMed ID: 16445063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial therapy in patients with diabetic foot syndrome].
    Palamarchuk VI; Siriachenko VH; Markov KV; Muz' MI; Shuliarenko OV; Shuliarenko LV
    Klin Khir; 2011 Jan; (1):49-52. PubMed ID: 21510362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patients with diabetic foot syndrome].
    Palamarchuk VI; Turaiev PI; Muz' MI; Shuliarenko OV; Hordiienko BO
    Klin Khir; 2010 Jan; (1):59-60. PubMed ID: 20469699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Microflora of purulent necrotic leisions of the foot in patients with diabetes mellitus].
    Svetukhin AM; Prokudina MV; Pavlova MV; Puchkova LS; Zemlianoĭ
    Antibiot Khimioter; 1995 Aug; 40(8):40-2. PubMed ID: 8713437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study--the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study.
    Mannucci E; Genovese S; Monami M; Navalesi G; Dotta F; Anichini R; Romagnoli F; Gensini G
    Acta Diabetol; 2014; 51(3):435-40. PubMed ID: 24352342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vast purulent necrotic lesions in patients with diabetes mellitus].
    Liul'ko IB; Kosul'nikov SO; Tarnopolskiĭ SA
    Klin Khir; 2001 Aug; (8):28-30. PubMed ID: 11794104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic therapy in the infected diabetic foot].
    Vieru A; Mazilu G; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1091-6. PubMed ID: 22276452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of the enteric sorbent "Silard P" in comprehensive treatment of diabetic foot syndrome].
    Shidlovs'kyĭ VO; Prokopchuk AI; Lishchenko NO
    Klin Khir; 1997; (11-12):39-40. PubMed ID: 9614998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRSA and osteomyelitis of the foot in diabetes.
    Game F; Jeffcoate W
    Diabet Med; 2004 Sep; 21 Suppl 4():16-9. PubMed ID: 15315521
    [No Abstract]   [Full Text] [Related]  

  • 17. [Restorative operations on main vessels for diabetic angiopathy of lower extremities with purulent-necrotic complications].
    Shor NA; Chumak IuF; Reuka VP; Zhukov OA
    Klin Khir; 2003 Sep; (9):20-2. PubMed ID: 14663904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of prostaglandin E1 and Naftidrofuryl in combined treatment of purulent-necrotic complications of the diabetic foot syndrome].
    Girka EI; Bazarinskaia ZI; Kravtsov EA
    Klin Khir; 2002; (11-12):21-2. PubMed ID: 12549263
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ways of improvement in surgical treatment of purulent-necrotic complications in the diabetic foot syndrome].
    Antoniuk SM; Sviridov NV; Golovnia PF; Andrienko IB; Akhrameev VB; Lomako AI
    Klin Khir; 2002; (11-12):91-3. PubMed ID: 12549315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary syndrome in patients with diabetic foot].
    Mazurok LM
    Klin Khir; 2001 Aug; (8):32-3. PubMed ID: 11794106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.